Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01087554
Title Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Temsirolimus

Everolimus

Sirolimus

Vorinostat

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.